Content about Pharmacy

PARSIPPANY, N.J. — The Food and Drug Administration will review an experimental contraceptive patch made by Actavis, the drug maker said Tuesday.

Actavis said the FDA accepted for review its application for norethindrone transdermal delivery system. The patch, which does not yet have a brand name, is designed to provide continuous delivery of norethindrone during a once-weekly, seven-day dosing regimen.

DUBLIN, Ohio — A new infographic released Tuesday created by the Cardinal Health Foundation and The Ohio State University College of Pharmacy helps illustrate prescription drug abuse in the United States.

Approximately 70% of people who abuse prescription medications get them from family or friends, often from medicine cabinets. On average, more than 10,000 people in the U.S. abuse prescription medications for the first time each day.

Americans and their healthcare plans are spending less on medicines and health services. Is that a good thing?

Researchers for the IMS Institute for Healthcare Informatics posed that question with the release of a report on the U.S. pharmaceutical market this week. But pharmacy leaders, independent and chain pharmacists, the U.S. health system and healthcare advocates are going to be dealing with the implications of that trend going forward.

WOONSOCKET, R.I. — A study conducted by researchers at CVS Caremark and Brigham and Women's Hospital and published in the May issue of the American Heart Journal found that non-white patients had 50% greater odds of statin medication nonadherence compared with white patients, while women had 10% greater odds of statin nonadherence compared with men.

WILMINGTON, Del. — Drug maker AstraZeneca is encouraging patients with asthma to control their disease and learn about how it may be affecting their lives as part of National Asthma and Allergy Awareness Month, which takes place in May.

WASHINGTON — The Generic Pharmaceutical Association has promoted Jason Money to associate VP federal government affairs, the trade group said Monday.

Money, who has worked for the GPhA for six years, was previously the organization's senior director for federal affairs. In the new position, he will continue lobbying on behalf of the generic drug industry in Congress.

 DEERFIELD, Ill. — Walgreens on Monday extended its agreement as a network pharmacy provider in the CVS Caremark pharmacy benefit management national retail network. The companies are not disclosing the financial and other confidential terms of the agreement.

PARSIPPANY, N.J. — Actavis is looking into the possibility of buying Warner Chilcott, the generic drug maker said Friday.

Actavis, the world's third-largest generic drug maker, said it had entered into early-stage discussions with Warner Chilcott about a potential combination of the two, but that no agreement had been reached, and that it wouldn't issue further comment about the matter.

SAN DIEGO — A biotech company and a nonprofit organization are looking into new ways to treat patients with the devastating degenerative disorder commonly known as Lou Gehrig's disease.

The ALS Emergency Treatment Fund and Denovo Biomarkers announced Friday a deal to explore the use of personalized medicine in treating patients with the disease, known medically as amyotrophic lateral sclerosis. The two said the approach could accelerate drug development in ALS and other life-threatening disorders.

EAST HANOVER, N.J. — The Food and Drug Administration has approved a biotech drug made by Novartis for treating a form of arthritis that affects children, the Swiss drug maker said Friday.

ALEXANDRIA, Va. — The National Community Pharmacists Association on Thursday announced it will host its NCPA Ownership Workshop from May 17 to 19 at the Seattle Airport Marriott. The Ownership Workshop, sponsored by McKesson and in part by Pharmacists Mutual and Live Oak Bank, gives prospective and current pharmacy owners an in-depth look at the industry and the financial, management and marketing skills needed to operate a successful pharmacy business. The three-day session also offers pharmacists 20 hours of continuing education credits.

TAMPA, Fla. — The Specialty Pharmacy Certification Board has appointed Terri Smith Moore as the education director, the group said Friday.

Moore is the senior manager for product development at healthcare accreditation organization URAC, where she manages the group's accreditation programs and revisions and maintenance of related accreditation documentation.